A troubling increase in sexually transmitted infections (STIs), particularly gonorrhoea and syphilis, has been reported in Europe, with cases reaching unprecedented levels in recent years. Health experts attribute this rise to shifting sexual behaviours and significant gaps in testing accessibility. The European Centre for Disease Prevention and Control (ECDC) has released alarming statistics showing that gonorrhoea cases surged by 303 per cent from 2015 to 2024, while syphilis cases more than doubled in the same timeframe.
Unprecedented Rise in STIs
Data from the ECDC highlights a concerning trend in STIs across Europe, with gonorrhoea cases climbing to a staggering 106,331 in 2024. Syphilis, meanwhile, has seen a dramatic escalation, reporting 45,577 cases—a significant increase compared to previous years. Chlamydia remains the most frequently diagnosed STI, with 213,443 cases noted in the latest figures.
Bruno Ciancio, head of the ECDC’s directly transmitted and vaccine-preventable diseases unit, stated, “Sexually transmitted infections have been on the rise for 10 years and reached record high levels in 2024.” He noted that untreated infections can lead to severe health issues, including chronic pain, infertility, and complications affecting the heart and nervous system in cases of syphilis.
Distressing Congenital Syphilis Cases
The report also draws attention to the alarming rise in congenital syphilis, where the infection is transmitted from mother to child during pregnancy. Cases of congenital syphilis have nearly doubled, increasing from 78 in 2023 to 140 in 2024 across 14 reporting countries. This trend poses significant long-term health risks for newborns, potentially leading to lifelong complications.
Health authorities have pointed out that men who have sex with men remain the most affected demographic, but the rise in syphilis cases is also becoming evident among heterosexual populations, particularly women of reproductive age.
The Need for Improved Testing and Treatment Access
One of the critical findings of the ECDC report is the “widening gaps” in STI testing. Alarmingly, 13 out of the 29 reporting countries still impose out-of-pocket costs for basic STI tests, which can discourage individuals from seeking the necessary medical care. Experts have called for immediate and decisive action from national healthcare bodies to improve access to testing and expedite treatment for STIs.
“Reversing increasing trends in STI cases requires accessible prevention services, easier access to testing, faster treatment, and stronger partner notification to stop onward transmission,” experts emphasised. The ECDC urges public health authorities to update national STI strategies and enhance surveillance systems to monitor the effectiveness of prevention efforts.
Addressing the Growing Health Crisis
As health professionals grapple with this growing crisis, the need for more robust public health initiatives has never been clearer. The rise in STIs not only affects individual health but also poses broader public health challenges, exacerbating inequalities in access to care and treatment.
Why it Matters
The surge in gonorrhoea and syphilis cases across Europe underscores a critical public health issue that demands immediate attention. With rising infection rates affecting diverse populations, particularly vulnerable groups, it is imperative for health authorities to prioritise accessible testing and treatment solutions. The long-term health consequences of untreated STIs can be catastrophic, not only for individuals but for society as a whole. A concerted effort to address these trends can help safeguard the health of future generations and reduce the burden on healthcare systems.
